[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![DermTimesNow Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::55642575.png) Dermatology Times [@DermTimesNow](/creator/twitter/DermTimesNow) on x 31.9K followers
Created: 2025-07-05 18:02:00 UTC

🗓 Review our recap of news from last week, including the FDA's RPD Designation of QRX003 for Netherton Syndrome, Galderma's X new clinical trials of nemolizumab, Allergan Aesthetics' sPMA for SKINVIVE by Juvéderm, and more.

#TheWeeklyRoundup #DermTwitter

![](https://pbs.twimg.com/media/GvHM46aXAAAHnzS.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1941558195702432072/c:line.svg)

**Related Topics**
[rpd](/topic/rpd)
[dermatology](/topic/dermatology)

[Post Link](https://x.com/DermTimesNow/status/1941558195702432072)